353 related articles for article (PubMed ID: 31454891)
21.
Lally ET; Boesze-Battaglia K; Dhingra A; Gomez NM; Lora J; Mitchell CH; Giannakakis A; Fahim SA; Benz R; Balashova N
Pathogens; 2020 Jan; 9(2):. PubMed ID: 31973183
[TBL] [Abstract][Full Text] [Related]
22. Leukotoxin (LtxA/Leukothera) induces ATP expulsion via pannexin-1 channels and subsequent cell death in malignant lymphocytes.
Prince DJ; Patel D; Kachlany SC
Sci Rep; 2021 Sep; 11(1):18086. PubMed ID: 34508147
[TBL] [Abstract][Full Text] [Related]
23. Computational modeling and druggability assessment of Aggregatibacter actinomycetemcomitans leukotoxin.
Hakmi M; Bouricha EM; El Harti J; Amzazi S; Belyamani L; Khanfri JE; Ibrahimi A
Comput Methods Programs Biomed; 2022 Jul; 222():106952. PubMed ID: 35724475
[TBL] [Abstract][Full Text] [Related]
24. Aggregatibacter actinomycetemcomitans induces detachment and death of human gingival epithelial cells and fibroblasts via elastase release following leukotoxin-dependent neutrophil lysis.
Hiyoshi T; Domon H; Maekawa T; Nagai K; Tamura H; Takahashi N; Yonezawa D; Miyoshi T; Yoshida A; Tabeta K; Terao Y
Microbiol Immunol; 2019 Mar; 63(3-4):100-110. PubMed ID: 30817027
[TBL] [Abstract][Full Text] [Related]
25. Aggregatibacter actinomycetemcomitans leukotoxin is post-translationally modified by addition of either saturated or hydroxylated fatty acyl chains.
Fong KP; Tang HY; Brown AC; Kieba IR; Speicher DW; Boesze-Battaglia K; Lally ET
Mol Oral Microbiol; 2011 Aug; 26(4):262-76. PubMed ID: 21729247
[TBL] [Abstract][Full Text] [Related]
26. Profound Effects of Aggregatibacter actinomycetemcomitans Leukotoxin Mutation on Adherence Properties Are Clarified in in vitro Experiments.
Velusamy SK; Sampathkumar V; Godboley D; Fine DH
PLoS One; 2016; 11(3):e0151361. PubMed ID: 26977924
[TBL] [Abstract][Full Text] [Related]
27. Monodisperse and LPS-free Aggregatibacter actinomycetemcomitans leukotoxin: interactions with human β2 integrins and erythrocytes.
Reinholdt J; Poulsen K; Brinkmann CR; Hoffmann SV; Stapulionis R; Enghild JJ; Jensen UB; Boesen T; Vorup-Jensen T
Biochim Biophys Acta; 2013 Feb; 1834(2):546-58. PubMed ID: 23234758
[TBL] [Abstract][Full Text] [Related]
28. Regulation of Aggregatibacter (Actinobacillus) actinomycetemcomitans leukotoxin secretion by iron.
Balashova NV; Diaz R; Balashov SV; Crosby JA; Kachlany SC
J Bacteriol; 2006 Dec; 188(24):8658-61. PubMed ID: 17041062
[TBL] [Abstract][Full Text] [Related]
29. Generation of a recombinant Aggregatibacter actinomycetemcomitans RTX toxin in Escherichia coli.
Balashova N; Giannakakis A; Brown AC; Koufos E; Benz R; Arakawa T; Tang HY; Lally ET
Gene; 2018 Sep; 672():106-114. PubMed ID: 29879499
[TBL] [Abstract][Full Text] [Related]
30. Cranberry Proanthocyanidins Neutralize the Effects of
Ben Lagha A; Howell A; Grenier D
Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31739483
[No Abstract] [Full Text] [Related]
31. Epigallocatechin gallate alters leukotoxin secretion and Aggregatibacter actinomycetemcomitans virulence.
Chang EH; Brown AC
J Pharm Pharmacol; 2021 Mar; 73(4):505-514. PubMed ID: 33793838
[TBL] [Abstract][Full Text] [Related]
32. Aggregatibacter (Actinobacillus) actimycetemcomitans leukotoxin and human periodontitis - A historic review with emphasis on JP2.
Tsai CC; Ho YP; Chou YS; Ho KY; Wu YM; Lin YC
Kaohsiung J Med Sci; 2018 Apr; 34(4):186-193. PubMed ID: 29655406
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the Virulence of Aggregatibacter actinomycetemcomitans Through the Analysis of Leukotoxin.
Nagasawa T; Kato S; Furuichi Y
Methods Mol Biol; 2021; 2210():185-193. PubMed ID: 32815139
[TBL] [Abstract][Full Text] [Related]
34. Sialic acid residues are essential for cell lysis mediated by leukotoxin from Aggregatibacter actinomycetemcomitans.
Munksgaard PS; Skals M; Reinholdt J; Poulsen K; Jensen MR; Yang C; Leipziger J; Vorup-Jensen T; Praetorius HA
Infect Immun; 2014 Jun; 82(6):2219-28. PubMed ID: 24643533
[TBL] [Abstract][Full Text] [Related]
35. Anti-leukemia activity of a bacterial toxin with natural specificity for LFA-1 on white blood cells.
Kachlany SC; Schwartz AB; Balashova NV; Hioe CE; Tuen M; Le A; Kaur M; Mei Y; Rao J
Leuk Res; 2010 Jun; 34(6):777-85. PubMed ID: 19747730
[TBL] [Abstract][Full Text] [Related]
36. Increased leukotoxin production: Characterization of 100 base pairs within the 530 base pair leukotoxin promoter region of Aggregatibacter actinomycetemcomitans.
Sampathkumar V; Velusamy SK; Godboley D; Fine DH
Sci Rep; 2017 May; 7(1):1887. PubMed ID: 28507341
[TBL] [Abstract][Full Text] [Related]
37. TdeA, a TolC-like protein required for toxin and drug export in Aggregatibacter (Actinobacillus) actinomycetemcomitans.
Crosby JA; Kachlany SC
Gene; 2007 Feb; 388(1-2):83-92. PubMed ID: 17116373
[TBL] [Abstract][Full Text] [Related]
38. Epigallocatechin gallate inhibits leukotoxin release by Aggregatibacter actinomycetemcomitans by promoting association with the bacterial membrane.
Chang EH; Giaquinto P; Huang J; Balashova NV; Brown AC
Mol Oral Microbiol; 2020 Jan; 35(1):29-39. PubMed ID: 31816197
[TBL] [Abstract][Full Text] [Related]
39. Aggregatibacter actinomycetemcomitans leukotoxin requires beta-sheets 1 and 2 of the human CD11a beta-propeller for cytotoxicity.
Kieba IR; Fong KP; Tang HY; Hoffman KE; Speicher DW; Klickstein LB; Lally ET
Cell Microbiol; 2007 Nov; 9(11):2689-99. PubMed ID: 17587330
[TBL] [Abstract][Full Text] [Related]
40. Characterization of leukotoxin from a clinical strain of Actinobacillus actinomycetemcomitans.
Diaz R; Ghofaily LA; Patel J; Balashova NV; Freitas AC; Labib I; Kachlany SC
Microb Pathog; 2006 Feb; 40(2):48-55. PubMed ID: 16414241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
